Skip to main content
. Author manuscript; available in PMC: 2022 Jan 11.
Published in final edited form as: Menopause. 2021 Jan 11;28(5):491–501. doi: 10.1097/GME.0000000000001730

Table 1.

Characteristics of the Women’s Interagency HIV Study participants by menopausal status.

Pre-menopausal (N=170) Post-menopausal (N=262) P-valuea Age-adjusted P-valueb
Age, y (mean ± SD) 44.6 ± 5.6 57.4 ± 5.9 <0.0001
Site (%) 0.77 0.09
   Bronx 46.5 49.6
   Brooklyn 27.6 27.1
   Chicago 25.9 23.3
Race (%) 0.20 0.29
   Black/African-American 58.8 63.7
   White 4.7 7.3
   Other or multi-racial 36.5 29.0
Hispanic (%) 32.4 23.3 0.05 0.30
Country of birth (%) 0.004 0.07
   U.S. 73.5 84
   Puerto Rico or other U.S. territories 3.5 5.3
   Other countries 22.9 10.7
Education (%) 0.96 0.28
   Grade 6 or less 1.2 2.3
   Grade 7-11 40.6 41.2
   Completed high school 30.0 29.8
   Some college 22.9 22.5
   Completed college or any graduate school 4.7 4.2
   Missing 0.6 0
Employed (%) 47.1 23.3 <0.0001 0.007
Alcohol use (%) 0.01 0.72
   Abstainer 45.3 61.1
   >0-7 drinks/wk 44.7 32.8
   >7-12 drinks/wk 4.7 3.1
   >12 drinks/wk 5.3 3.1
Cigarette smoking history (%) 0.005 0.04
   Never smoker 28.8 17.9
   Current smoker 40.6 37.8
   Former smoker 30.6 44.3
Recreational drug use (%) 30.6 17.2 0.001 0.86
Hormonal contraceptive use (%) 6.5 0.4 0.0002 0.46
HIV-positive (%) 58.2 69.5 0.02 0.73
Detectable HIV viral loadc (% among HIV+) 28.3 21.4 0.24 0.75
HIV therapy (% among HIV+) 90.9 96.2 0.10 0.43
HCV antibody detectable (%) 7.1 34.0 <0.0001 0.19
BMI, kg/m2 (mean ± SD) 32.5 ± 8.1 30.4 ± 7.6 0.004 0.02
Diabetes (%) 17.6 34.7 0.0001 0.17
Hypertension (%) 36.5 65.3 <0.0001 0.16
a

P-values from Wilcoxon rank-sum test for continuous variables and Fisher’s exact test for categorical variables.

b

P-values are from likelihood ratio tests comparing a logistic model with age and the variable of interest to a model with age alone.

c

Lower limit of detection = 20 copies/mL